45 CFR § 180 compliance
B · 80
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
○Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
1,169
Insurances with rates
0
CPT / HCPCS codes
1,111
Source MRF
Most expensive procedures (gross)
J3357
$37,574
Injection, ustekinumab, 1 mg
Gross
$37,574
617
$36,347
DRG AMPUTATION OF LOWER LIMB FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH COMPLICATION OR
Gross
$36,347
623
$36,026
DRG SKIN GRAFTS AND WOUND DEBRIDEMENT FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH COMPLI
Gross
$36,026
554
$26,309
DRG BONE DISEASES AND ARTHROPATHIES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, P
Gross
$26,309
J9354
$25,237
HC INJ, ADO-TRASTUZUMAB EMT 1MG
Gross
$25,237
470
$25,099
DRG MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBI
Gross
$25,099
392
$21,810
DRG ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR
Gross
$21,810
603
$20,789
DRG CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE,
Gross
$20,789
J9312
$18,709
HC RITUXIMAB 10 MG INJ
Gross
$18,709
638
$18,682
DRG DIABETES WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUT
Gross
$18,682
J3101
$17,775
Injection, Tenecteplase, 1 mg
Gross
$17,775
J9308
$17,258
HC INJECTION, RAMUCIRUMAB 5 MG
Gross
$17,258
637
$15,361
DRG DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC)
Gross
$15,361
699
$15,256
DRG OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC)
Gross
$15,256
J9311
$15,012
Inj rituximab, hyaluronidase
Gross
$15,012
580
$13,939
DRG OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)
Gross
$13,939
C1776
$13,808
HC JOINT DEVICE (IMPLANTABLE) LVL 45
Gross
$13,808
L8699
$13,808
HC PROSTHETIC IMPLANT NOS LVL 21
Gross
$13,808
J9299
$13,480
HC INJECTION, NIVOLUMAB 1 MG
Gross
$13,480
193
$13,258
DRG SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVAL
Gross
$13,258
J2997
$13,229
Injection, alteplase recombinant, 1 mg
Gross
$13,229
J3380
$12,938
Injection, vedolizumab
Gross
$12,938
90375
$12,422
Rabies immune globulin (RIg), human, for intramuscular and/or subcutaneous use
Gross
$12,422
292
$12,369
DRG HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, INCIDEN
Gross
$12,369
J9305
$12,142
Injection, pemetrexed, 10 mg
Gross
$12,142
R0101
$11,216
Gross
$11,216
195
$10,972
DRG SIMPLE PNEUMONIA AND PLEURISY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COM
Gross
$10,972
897
$10,546
DRG ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR C
Gross
$10,546
J1569
$10,499
Injection, immune globulin, (gammagard liquid), intravenous, non-lyophilized, (e.g. liquid), 500 mg
Gross
$10,499
690
$10,254
DRG KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC)
Gross
$10,254
935
$10,233
DRG NON-EXTENSIVE BURNS
Gross
$10,233
J2353
$10,190
Injection, octreotide, depot form for intramuscular injection, 1 mg
Gross
$10,190
546
$10,153
CONNECTIVE TISSUE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, INCIDEN
Gross
$10,153
871
$9,890
DRG SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) -
Gross
$9,890
440
$9,252
DRG DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICAT
Gross
$9,252
J2505
$9,113
Injection, Pegfilgrastim, 6 mg
Gross
$9,113
J9171
$9,016
Injection, docetaxel, 1 mg
Gross
$9,016
566
$8,462
DRG OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DIAGNOSES WITHOUT COMPLICATION OR COMORBIDITY
Gross
$8,462
194
$8,389
DRG SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, I
Gross
$8,389
390
$8,038
DRG G.I. OBSTRUCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC
Gross
$8,038
785
$7,873
DRG CESAREAN SECTION WITH STERILIZATION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION
Gross
$7,873
788
$7,733
DRG CESAREAN SECTION WITHOUT STERILIZATION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATI
Gross
$7,733
191
$7,701
DRG CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVA
Gross
$7,701
806
$7,687
DRG VAGINAL DELIVERY WITHOUT STERILIZATION/D&C WITH COMPLICATION OR COMORBIDITY (CC)
Gross
$7,687
J9035
$7,478
Injection, bevacizumab, 10 mg
Gross
$7,478
446
$7,319
DRG DISORDERS OF THE BILIARY TRACT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR CO
Gross
$7,319
176
$7,259
DRG PULMONARY EMBOLISM WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC)
Gross
$7,259
783
$6,970
CESAREAN SECTION WITH STERILIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREV
Gross
$6,970
641
$6,750
DRG MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLIC
Gross
$6,750
208
$6,709
DRG RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS
Gross
$6,709
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J3357 | Injection, ustekinumab, 1 mg | $37,574 | $37,574 | $17,338 | $137,368 | 0 |
| 617 | DRG AMPUTATION OF LOWER LIMB FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH COMPLICATION OR | $36,347 | $36,347 | $16,772 | $132,882 | 0 |
| 623 | DRG SKIN GRAFTS AND WOUND DEBRIDEMENT FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH COMPLI | $36,026 | $36,026 | $15,567 | $131,706 | 0 |
| 554 | DRG BONE DISEASES AND ARTHROPATHIES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, P | $26,309 | $26,309 | $6,168 | $96,184 | 0 |
| J9354 | HC INJ, ADO-TRASTUZUMAB EMT 1MG | $25,237 | $25,237 | $11,645 | $92,264 | 0 |
| 470 | DRG MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBI | $25,099 | $25,099 | $11,582 | $91,762 | 0 |
| 392 | DRG ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR | $21,810 | $21,810 | $6,594 | $79,733 | 0 |
| 603 | DRG CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, | $20,789 | $20,789 | $9,593 | $76,001 | 0 |
| J9312 | HC RITUXIMAB 10 MG INJ | $18,709 | $18,709 | $8,633 | $68,398 | 0 |
| 638 | DRG DIABETES WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUT | $18,682 | $18,682 | $8,621 | $68,299 | 0 |
| J3101 | Injection, Tenecteplase, 1 mg | $17,775 | $17,775 | $8,202 | $64,985 | 0 |
| J9308 | HC INJECTION, RAMUCIRUMAB 5 MG | $17,258 | $17,258 | $7,964 | $63,094 | 0 |
| 637 | DRG DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | $15,361 | $15,361 | $6,235 | $56,159 | 0 |
| 699 | DRG OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | $15,256 | $15,256 | $7,040 | $55,775 | 0 |
| J9311 | Inj rituximab, hyaluronidase | $15,012 | $15,012 | $6,927 | $54,884 | 0 |
| 580 | DRG OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | $13,939 | $13,939 | $6,432 | $50,960 | 0 |
| C1776 | HC JOINT DEVICE (IMPLANTABLE) LVL 45 | $13,808 | $13,808 | $6,372 | $50,481 | 0 |
| L8699 | HC PROSTHETIC IMPLANT NOS LVL 21 | $13,808 | $13,808 | $6,372 | $50,481 | 0 |
| J9299 | HC INJECTION, NIVOLUMAB 1 MG | $13,480 | $13,480 | $6,220 | $49,283 | 0 |
| 193 | DRG SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVAL | $13,258 | $13,258 | $6,118 | $48,470 | 0 |
| J2997 | Injection, alteplase recombinant, 1 mg | $13,229 | $13,229 | $113 | $48,364 | 0 |
| J3380 | Injection, vedolizumab | $12,938 | $12,938 | $5,970 | $47,300 | 0 |
| 90375 | Rabies immune globulin (RIg), human, for intramuscular and/or subcutaneous use | $12,422 | $12,422 | $2,918 | $45,415 | 0 |
| 292 | DRG HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, INCIDEN | $12,369 | $12,369 | $5,707 | $45,218 | 0 |
| J9305 | Injection, pemetrexed, 10 mg | $12,142 | $12,142 | $5,603 | $44,391 | 0 |
| R0101 | $11,216 | $11,216 | $5,176 | $41,005 | 0 | |
| 195 | DRG SIMPLE PNEUMONIA AND PLEURISY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COM | $10,972 | $10,972 | $5,063 | $40,113 | 0 |
| 897 | DRG ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR C | $10,546 | $10,546 | $4,866 | $38,554 | 0 |
| J1569 | Injection, immune globulin, (gammagard liquid), intravenous, non-lyophilized, (e.g. liquid), 500 mg | $10,499 | $10,499 | $3,281 | $38,384 | 0 |
| 690 | DRG KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | $10,254 | $10,254 | $4,732 | $37,487 | 0 |
| 935 | DRG NON-EXTENSIVE BURNS | $10,233 | $10,233 | $3,456 | $37,412 | 0 |
| J2353 | Injection, octreotide, depot form for intramuscular injection, 1 mg | $10,190 | $10,190 | $4,702 | $37,254 | 0 |
| 546 | CONNECTIVE TISSUE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, INCIDEN | $10,153 | $10,153 | $4,685 | $37,119 | 0 |
| 871 | DRG SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - | $9,890 | $9,890 | $4,564 | $36,158 | 0 |
| 440 | DRG DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICAT | $9,252 | $9,252 | $4,269 | $33,824 | 0 |
| J2505 | Injection, Pegfilgrastim, 6 mg | $9,113 | $9,113 | $4,058 | $33,316 | 0 |
| J9171 | Injection, docetaxel, 1 mg | $9,016 | $9,016 | $4,160 | $32,962 | 0 |
| 566 | DRG OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DIAGNOSES WITHOUT COMPLICATION OR COMORBIDITY | $8,462 | $8,462 | $3,905 | $30,939 | 0 |
| 194 | DRG SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, I | $8,389 | $8,389 | $3,871 | $30,669 | 0 |
| 390 | DRG G.I. OBSTRUCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC | $8,038 | $8,038 | $3,652 | $29,388 | 0 |
| 785 | DRG CESAREAN SECTION WITH STERILIZATION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION | $7,873 | $7,873 | $3,633 | $28,784 | 0 |
| 788 | DRG CESAREAN SECTION WITHOUT STERILIZATION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATI | $7,733 | $7,733 | $3,568 | $28,270 | 0 |
| 191 | DRG CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVA | $7,701 | $7,701 | $3,553 | $28,152 | 0 |
| 806 | DRG VAGINAL DELIVERY WITHOUT STERILIZATION/D&C WITH COMPLICATION OR COMORBIDITY (CC) | $7,687 | $7,687 | $3,547 | $28,104 | 0 |
| J9035 | Injection, bevacizumab, 10 mg | $7,478 | $7,478 | $3,407 | $27,339 | 0 |
| 446 | DRG DISORDERS OF THE BILIARY TRACT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR CO | $7,319 | $7,319 | $3,378 | $26,759 | 0 |
| 176 | DRG PULMONARY EMBOLISM WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | $7,259 | $7,259 | $2,790 | $26,539 | 0 |
| 783 | CESAREAN SECTION WITH STERILIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREV | $6,970 | $6,970 | $3,216 | $25,482 | 0 |
| 641 | DRG MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLIC | $6,750 | $6,750 | $3,115 | $24,675 | 0 |
| 208 | DRG RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | $6,709 | $6,709 | $3,096 | $24,527 | 0 |
Showing top 50 of 1,169 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.